Navigation Links
Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis
Date:12/17/2009

WALTHAM, MA Brandeis University selected Jay and Maureen Neitz, the husband-and-wife team whose pioneering research may lead to the use of gene therapy to treat vision disorders, as the inaugural recipients of the Jay Pepose '75 Award in Vision Sciences.

The award is funded by a $1 million endowment established this year through a gift from Brandeis graduates Jay Pepose '75 and Susan K. Feigenbaum '74, his wife. The endowment primarily supports graduate research fellowships in vision science.

The Neitzes, both of whom are faculty members in the Department of Ophthalmology at the University of Washington in Seattle, will visit Brandeis to receive the Pepose Award. They will each deliver a public lecture in Gerstenzang 121: Jay will discuss "Gene Therapy for Red-Green Color Blindness in Adult Primates" at 3:30 p.m. on Feb. 8, and Maureen will talk about "Retinal Activity Patterns and the Cause and Prevention of Nearsightedness" at noon on Feb. 9.

Pepose is a professor of clinical ophthalmology at Washington University and the owner and medical director of the Pepose Vision Institute in St. Louis. During his time as an undergraduate, Pepose worked closely with John Lisman, the Zalman Abraham Kekst Chair in Neuroscience and Professor of Biology at Brandeis. He was part of the inaugural class of Fellows inducted into the Association for Research in Vision and Ophthalmology (ARVO) in 2009.

"We look forward to the Neitzes' visit to campus to discuss their groundbreaking research," said Brandeis President Jehuda Reinharz, PhD '72. "We thank Jay and Susan, whose gift to establish the Pepose Award in Vision Sciences has made it possible for Brandeis faculty and students to learn more about the Neitzes' work."

In a recent issue of the journal Nature, the Neitzes and their colleagues detailed a study in which they used gene therapy to cure two squirrel monkeys of color blindness. The research offers hope for the use of gene therapy to treat adult vision disorders involving cone cells the most important cells for vision in humans.

"The Neitzes' recent paper in Nature will revolutionize the way we understand color perception," Pepose said. "I am delighted that Brandeis has chosen such outstanding contributors to vision research for this award."


'/>"/>

Contact: Laura Gardner
gardner@brandeis.edu
781-736-4204
Brandeis University
Source:Eurekalert

Related medicine news :

1. Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division
2. Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference
3. PAL Browser, Helpful Software Available for Those with Mobility and Vision Problems
4. Early Treatment of Hearing, Vision Helps in Schizophrenia
5. Enhanced Vision Named as one of Orange County's Top Workplaces in 2009
6. LCA-Vision Joins Forces With the Wounded Warrior Project to Give the Gift of Enhanced Vision to Wounded American Heroes
7. VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution
8. New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director
9. Brandeis studies evaluate visionary approach to improving eyesight
10. NCOA, Bedlin Brief Leading Aging Organizations on Health Care Reform, Needed Long-Term Care Provisions
11. Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... 18, 2017 , ... Moore Insurance, a Houston area agency ... is launching a regional charity effort to provide publicity assistance and generate donations ... Tumor Foundation (PBTF) has raised nearly $30 million in donations that has been ...
(Date:8/18/2017)... ... August 18, 2017 , ... Goss & ... serves residential and commercial clients in the greater Houston region, is helping locally ... for the fight against cancer. , Founded by Tony and Amber Bender after ...
(Date:8/18/2017)... ... August 18, 2017 , ... With over 16,000 active ... hormone replacement therapy and integrative medicine, has become a frontrunner for people seeking ... as menopause, andropause, thyroid disorder and adrenal insufficiencies. , Founded in 2003 ...
(Date:8/18/2017)... IN (PRWEB) , ... August 18, 2017 , ... Inc. ... annual list, the most prestigious ranking of the nation's fastest-growing private companies. This marks ... the exclusive Inc. 5000 ranking . This year’s ranking reflects ASH’s 76 percent ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Dangerous Inheritance”: a mystery about ... Winters. Diane is from Southwest Nebraska where she was raised on a farm. ... The story is fictional, but the friendships and mantra of ‘neighbors helping neighbors’ ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... Ore. , Aug. 2, 2017  Life Flight Network ... Agreement. The agreement improves patient care and operational efficiency for ... Springfield , Cottage Grove , ... level medical transportation. PeaceHealth and Life Flight Network work collaboratively ... available during transport, or when a time sensitive emergency exists. ...
(Date:7/31/2017)...  Diplomat Pharmacy, Inc. (NYSE: DPLO), has been named one ... by Crain,s Detroit Business . The annual ... three-year revenue growth. This year,s edition measures growth from 2013 ... the complete list, visit crainsdetroit.com/awards/fast_50/2017 .  ... said Phil Hagerman , CEO and chairman of Diplomat. ...
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
Breaking Medicine Technology: